LeMaitre Vascular, Inc. (LMAT)
77.65
-1.64
(-2.07%)
USD |
NASDAQ |
Nov 12, 16:00
77.66
+0.02
(+0.02%)
After-Hours: 20:00
LeMaitre Vascular Enterprise Value : 1.576B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.576B |
| November 11, 2026 | 1.613B |
| November 10, 2026 | 1.607B |
| November 09, 2026 | 1.656B |
| November 06, 2026 | 1.650B |
| November 05, 2026 | 1.709B |
| November 04, 2026 | 1.811B |
| November 03, 2026 | 1.643B |
| November 02, 2026 | 1.658B |
| October 30, 2026 | 1.651B |
| October 29, 2026 | 1.750B |
| October 28, 2026 | 1.695B |
| October 27, 2026 | 1.716B |
| October 26, 2026 | 1.728B |
| October 23, 2026 | 1.731B |
| October 22, 2026 | 1.752B |
| October 21, 2026 | 1.714B |
| October 20, 2026 | 1.707B |
| October 19, 2026 | 1.682B |
| October 16, 2026 | 1.648B |
| October 15, 2026 | 1.702B |
| October 14, 2026 | 1.690B |
| October 13, 2026 | 1.665B |
| October 12, 2026 | 1.696B |
| October 09, 2026 | 1.645B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.621B |
| October 07, 2026 | 1.614B |
| October 06, 2026 | 1.608B |
| October 05, 2026 | 1.652B |
| October 02, 2026 | 1.606B |
| October 01, 2026 | 1.634B |
| September 30, 2026 | 1.689B |
| September 29, 2026 | 1.709B |
| September 28, 2026 | 1.697B |
| September 25, 2026 | 1.678B |
| September 24, 2026 | 1.662B |
| September 23, 2026 | 1.656B |
| September 22, 2026 | 1.666B |
| September 21, 2026 | 1.625B |
| September 18, 2026 | 1.617B |
| September 17, 2026 | 1.631B |
| September 16, 2026 | 1.652B |
| September 15, 2026 | 1.649B |
| September 14, 2026 | 1.661B |
| September 11, 2026 | 1.657B |
| September 10, 2026 | 1.616B |
| September 09, 2026 | 1.631B |
| September 08, 2026 | 1.634B |
| September 04, 2026 | 1.659B |
| September 03, 2026 | 1.654B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 213.21B |
| AngioDynamics, Inc. | 485.22M |
| Alphatec Holdings, Inc. | 1.621B |
| AtriCure, Inc. | 2.760B |
| Baxter International, Inc. | 19.33B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.02M |
| Revenue (Quarterly) | 67.97M |
| Total Expenses (Quarterly) | 52.95M |
| EPS Diluted (Quarterly) | 0.6512 |
| Gross Profit Margin (Quarterly) | 69.54% |
| Profit Margin (Quarterly) | 22.10% |
| Earnings Yield | 3.48% |
| Operating Earnings Yield | 4.11% |
| Normalized Earnings Yield | 3.484 |